Table of Contents
<< Previous Issue | Oct 2013 (Vol: 2013, Issue: 10) | Next Issue >> |
- Section: Licensing
-
Ablynx Advances Ambitions by Partnering with AbbVie and Merck Serono
-
Hutchison MediPharma Partners with Eli Lilly to Advance Development of Fruquintinib in China
- Section: Mergers & Acquisitions
-
AstraZeneca Acquires Spirogen for Next-Generation Antibody-Drug Conjugate Platform
- Section: Research & Development
-
Galapagos and AbbVie Aim to Compete with Vertex in Cystic Fibrosis Market
-
Stallergenes and DBV Technologies Partner to Develop Birch Pollen Allergy Immunotherapy